申请人:Glaxo Group Limited
公开号:US08318940B2
公开(公告)日:2012-11-27
Compounds of Formula (I),
wherein substituents R1, R2 and R5 are as defined, and Ar represents substituted phenyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, furanyl, imidazolyl and thiophenyl substituted by a hydroxyalkyl substituent and an optional other substituent; compositions containing them, their use in therapy, including their use as antibacterials, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.
提供式(I)的化合物,其中取代基R1、R2和R5如定义,Ar代表被羟基烷基取代和可选其他取代基取代的取代苯基、吡啶基、吡嗪基、嘧啶基、吡咯嗪基、噻唑基、呋喃基、咪唑基和噻吩基;包含它们的组合物,它们在治疗中的使用,包括它们作为抗菌剂的使用,例如在结核病的治疗中,并提供这种化合物的制备方法。